Indication Target Mode of Action
Lead Generation
Feasibility
Candidate Selection
IND Enabling
Oncology
STING
Agonist
IND enabling
Inflammation
STING
Antagonist
Lead Generation stage
Oncology
ACSS2
Inhibitor
Candidate Selection stage
Oncology
TDO/IDO
Inhibitor
IND enabling stage
Oncology
HPK1
Inhibitor
Lead Generation stage
Lead Generation stage